Research Article

Molecular Biology of Breast Cancer in the Horn of Africa: Case Series—A Pilot Study of Breast Cancer from Eritrea

Table 1

Summary of the clinical pathological characteristics of molecular subtypes of breast cancer in Eritrea.

Molecular subtypes of breast cancer

CharacteristicsAll cases
(100)
Luminal A
(59)
Luminal B
(4.5)
HER2 type
(4.5)
Basal-like
(9.1)
Unclassified
(22.7)
value
(%) (%) (%) (%) (%) (%)

Sex
 Male2 (9.1)2 (18.2)0 (0)0 (0)0 (0)0 (0)0.70
 Female20 (90.9)11 (84.6)1 (100)1 (100)2 (100)5 (100)
Age in years
 <5013 (63.6)7 (63.6)1024 (80)0.26
>50 (age unknown in one patient) 8 (36.4)4 (36.4)02 02 (20)
 Mean (SD)47.7 (12.9)
Histologic type
 IC (NST)20 (91)10 (90.1)12 160.18
 Colloid1 (4.5)1 (9.9)0000
 Metaplastic breast carcinoma (SCC)1 (4.5)00010
Nottingham grade
 I2 (9.1)2 (18.2)0 0 000.031
 II7 (31.8)6 (54.5)0 0 01 (16.7)
 III13 (59.1)3 (27.3)1 2 25 (83.3)
LN* metastasis
 Positive11 (50)6 (54.5)1 1 1 (50)2 (33.3)0.44
 Negative8 (36.4)5 (45.5)0 0 02 (33.3)
 NA3 (13.6)00 0 1 (50)2 (33.3)
Tumor size
 ≤2 cm1 (4.5) 1 (9.1)0 0 000.84
 2.1–5 cm12 (54.6)6 (54.5)1 1 04
 >5 cm7 (31.8)4 (36.4)0 1 11
 NA2 (9.1)00 0 11
LVI**
 Positive3 (13.6)1 (9.9)1 0 1 (50)00.04
 Negative19 (86.4) 10 (90.1)0 2 1 (50)6
ITN+
 Positive10 (45.4)4 (36.4)1 2 03 (50)0.11
 Negative12 (54.6)7 (63.6)0 0 23 (50)

ITN+: invasive tumour necrosis, LVI**: lymphatic vessel invasion, LN*: lymph node, IC (NST): invasive carcinoma of no special type, NA: Nonavailable, : probability, SD: standard deviation, SCC: squamous cell carcinoma.